GO
Loading...

Kite Pharma's positive cancer drug study results

Wednesday, 27 Aug 2014 | 2:25 PM ET

Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.